Paris-based Waiv, which uses AI to enable more precise testing of cancer, raised $33M after spinning out of AI diagnostics and drug discovery platform Owkin Sifted 2026-03-13 Martin Coulter AI, Waiv Related Coverage AI Drug Discovery Startup Earendil Is Said to Consider Hong Kong IPO Bloomberg Waiv Raises $33M in Funding FinSMEs Waiv Secures $33 Million to Scale AI Precision Testing Business Wire Owkin Creates New Spin out Waiv, Formerly Owkin Dx, With $33M Financing Business Wire Exclusive: Waiv raises $33M for AI precision platform Axios · Katherine Davis 🇫🇷 French Tech Wire: Elaia's Billion-Euro Bet on Venture's Future The French Tech Journal · Chris O'Brien